FluroTech Ltd. (FLURF)
USD 0.0
(N/A%)
USD 0.0
(N/A%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 227.73 Thousand CAD | -45.3% |
| 2022 | 416.35 Thousand CAD | -66.8% |
| 2021 | 1.25 Million CAD | 65.58% |
| 2020 | 757.36 Thousand CAD | -79.0% |
| 2019 | 3.6 Million CAD | -42.01% |
| 2018 | 6.21 Million CAD | 4073.25% |
| 2017 | 149.01 Thousand CAD | -23.82% |
| 2016 | 195.59 Thousand CAD | -14.78% |
| 2015 | 229.51 Thousand CAD | -20.44% |
| 2014 | 288.47 Thousand CAD | -14.25% |
| 2013 | 336.4 Thousand CAD | -26.52% |
| 2012 | 457.81 Thousand CAD | -7.64% |
| 2011 | 495.69 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 264.05 Thousand CAD | 15.95% |
| 2024 Q2 | 755.83 Thousand CAD | 186.25% |
| 2023 FY | 227.73 Thousand CAD | -45.3% |
| 2023 Q4 | 227.73 Thousand CAD | -18.83% |
| 2023 Q2 | 273.66 Thousand CAD | -5.78% |
| 2023 Q3 | 280.57 Thousand CAD | 2.52% |
| 2023 Q1 | 290.47 Thousand CAD | -30.23% |
| 2022 Q4 | 416.35 Thousand CAD | -57.78% |
| 2022 Q3 | 986.12 Thousand CAD | -2.26% |
| 2022 Q1 | 1.04 Million CAD | -16.78% |
| 2022 FY | 416.35 Thousand CAD | -66.8% |
| 2022 Q2 | 1 Million CAD | -3.33% |
| 2021 Q1 | 3.03 Million CAD | 300.27% |
| 2021 Q3 | 8.82 Million CAD | -10.6% |
| 2021 FY | 1.25 Million CAD | 65.58% |
| 2021 Q4 | 1.25 Million CAD | -85.79% |
| 2021 Q2 | 9.87 Million CAD | 225.69% |
| 2020 Q3 | 1.74 Million CAD | -19.31% |
| 2020 Q4 | 757.36 Thousand CAD | -56.49% |
| 2020 Q1 | 2.53 Million CAD | -29.78% |
| 2020 FY | 757.36 Thousand CAD | -79.0% |
| 2020 Q2 | 2.15 Million CAD | -14.8% |
| 2019 Q3 | 4.66 Million CAD | -15.81% |
| 2019 Q4 | 3.6 Million CAD | -22.68% |
| 2019 FY | 3.6 Million CAD | -42.01% |
| 2019 Q1 | 6.38 Million CAD | 2.66% |
| 2019 Q2 | 5.53 Million CAD | -13.23% |
| 2018 Q2 | 8.17 Million CAD | 5493.43% |
| 2018 FY | 6.21 Million CAD | 4073.25% |
| 2018 Q4 | 6.21 Million CAD | -18.09% |
| 2018 Q3 | 7.59 Million CAD | -7.13% |
| 2018 Q1 | 146.14 Thousand CAD | -1.92% |
| 2017 Q4 | 149.01 Thousand CAD | -5.25% |
| 2017 FY | 149.01 Thousand CAD | -23.82% |
| 2017 Q3 | 157.26 Thousand CAD | -1.41% |
| 2017 Q2 | 159.51 Thousand CAD | -15.6% |
| 2017 Q1 | 188.99 Thousand CAD | -3.38% |
| 2016 FY | 195.59 Thousand CAD | -14.78% |
| 2016 Q1 | 228.28 Thousand CAD | -0.54% |
| 2016 Q2 | 203.09 Thousand CAD | -11.04% |
| 2016 Q4 | 195.59 Thousand CAD | -2.13% |
| 2016 Q3 | 199.85 Thousand CAD | -1.6% |
| 2015 Q3 | 245.24 Thousand CAD | -1.68% |
| 2015 Q2 | 249.42 Thousand CAD | -7.19% |
| 2015 FY | 229.51 Thousand CAD | -20.44% |
| 2015 Q4 | 229.51 Thousand CAD | -6.41% |
| 2015 Q1 | 268.74 Thousand CAD | -6.84% |
| 2014 Q3 | 289.87 Thousand CAD | -4.08% |
| 2014 Q4 | 288.47 Thousand CAD | -0.48% |
| 2014 Q2 | 302.21 Thousand CAD | -4.04% |
| 2014 FY | 288.47 Thousand CAD | -14.25% |
| 2014 Q1 | 314.92 Thousand CAD | -6.38% |
| 2013 Q4 | 336.4 Thousand CAD | -2.25% |
| 2013 Q3 | 344.15 Thousand CAD | -12.76% |
| 2013 Q2 | 394.5 Thousand CAD | -9.41% |
| 2013 Q1 | 435.47 Thousand CAD | -4.88% |
| 2013 FY | 336.4 Thousand CAD | -26.52% |
| 2012 Q2 | 475.22 Thousand CAD | -2.47% |
| 2012 Q1 | 487.25 Thousand CAD | -1.7% |
| 2012 Q4 | 457.81 Thousand CAD | -1.81% |
| 2012 FY | 457.81 Thousand CAD | -7.64% |
| 2012 Q3 | 466.22 Thousand CAD | -1.89% |
| 2011 Q2 | 518.66 Thousand CAD | -4.56% |
| 2011 Q4 | 495.69 Thousand CAD | -0.23% |
| 2011 Q1 | 543.43 Thousand CAD | 0.0% |
| 2011 FY | 495.69 Thousand CAD | 0.0% |
| 2011 Q3 | 496.83 Thousand CAD | -4.21% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Avitar, Inc. | 1.74 Million USD | 86.97% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Manhattan Scientifics, Inc. | 316 Thousand USD | 27.931% |
| Urologix, Inc. | 5.66 Million USD | 95.981% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | 89.352% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | -573.898% |
| CVR Medical Corp. | - USD | -Infinity% |
| Össur hf. | 1.39 Billion USD | 99.984% |
| Össur hf. | 1.39 Billion USD | 99.984% |
| SS Innovations International, Inc. | 25.47 Million USD | 99.106% |
| VMS Rehab Systems, Inc. | 4.45 USD | -5117585.393% |
| QHSLab, Inc. | 1.68 Million USD | 86.456% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| BrainsWay Ltd. | 62.97 Million USD | 99.638% |
| BioElectronics Corporation | 144.38 Thousand USD | -57.726% |
| Hamilton Thorne Ltd. | 110.16 Million USD | 99.793% |
| Theraclion SA | 18.66 Million EUR | 98.78% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.76 Million USD | 87.116% |
| Stratec SE | 529.71 Million USD | 99.957% |
| AVITA Medical, Inc. | 144.33 Million USD | 99.842% |
| Nu-Med Plus, Inc. | 2.21 Million USD | 89.705% |
| Zecotek Photonics Inc. | 2.57 Million USD | 91.149% |
| Wellstar International, Inc. | 957.89 Thousand USD | 76.225% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | 99.779% |
| Escalon Medical Corp. | 4.75 Million USD | 95.214% |
| Guided Therapeutics, Inc. | 1.66 Million USD | 86.355% |
| Aurora Spine Corporation | 11.92 Million USD | 98.09% |
| NewCardio, Inc. | 2.85 Million USD | 92.018% |
| Vivos Inc. | 1.61 Million USD | 85.856% |
| MicroPort Scientific Corporation | 3.93 Billion USD | 99.994% |
| Kelyniam Global, Inc. | 1.63 Million USD | 86.051% |
| REMSleep Holdings, Inc. | 1.2 Million USD | 81.121% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | -315.973% |
| Nanomix Corporation | 982.05 Thousand USD | 76.81% |
| IR-Med Inc. | 999 Thousand USD | 77.204% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | -25.007% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | 69.569% |
| Lombard Medical, Inc. | 67.76 Million USD | 99.664% |
| ALR Technologies Inc. | 193.21 Thousand USD | -17.866% |
| Vycor Medical, Inc. | 992.29 Thousand USD | 77.05% |
| Heart Tronics, Inc. | 4.04 Million USD | 94.375% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | 98.891% |
| SANUWAVE Health, Inc. | 22.41 Million USD | 98.984% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | 69.13% |
| United American Healthcare Corporation | 10.37 Million USD | 97.806% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | 50.035% |
| ECGI Holdings, Inc. | 5.2 Million USD | 95.622% |
| Polarean Imaging plc | 10.86 Million USD | 97.904% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | 73.847% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | 89.899% |
| Nexeon MedSystems Inc. | 20.35 Million USD | 98.881% |
| Qualis Innovations, Inc. | 2431.00 USD | -9268.038% |
| Smith & Nephew plc | 9.97 Billion USD | 99.998% |
| NIOX Group Plc | 116.47 Million USD | 99.804% |
| Fuse Medical, Inc. | 16.25 Million USD | 98.599% |
| Broncus Holding Corporation | 195.75 Million USD | 99.884% |
| Brain Scientific Inc. | 11.74 Million USD | 98.061% |
| Pressure BioSciences, Inc. | 1.04 Million USD | 78.304% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | -692.542% |